Areas Of Interest
- Obesity and the use of NOACs
- Stroke Prevention in Atrial Fibrillation with NOACs
- Dual pathway inhibition antithrombotic therapy to reduce major adverse vascular events in patients with chronic CAD and/or PAD
- Identification of high risk medically ill patients and the role of thromboprophylaxis post discharge
Certificate Of Separation
Please click here to view the certificate of separation.
For general questions please email to [email protected].